(Q40082926)

17 September 2017

Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1. (English)

1 reference

17 September 2017

1 reference

W-G Deng

1

1 reference

17 September 2017

G Wu

2

1 reference

17 September 2017

K Ueda

3

1 reference

17 September 2017

K Xu

4

1 reference

17 September 2017

J A Roth

5

1 reference

17 September 2017

L Ji

6

1 reference

17 September 2017

7 September 2007

1 reference

17 September 2017

1 reference

17 September 2017

15

1 reference

17 September 2017

1

1 reference

17 September 2017

29-39

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701094

17 September 2017

0 references

cites work

Novel approaches to locally advanced unresectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

New therapeutic approaches for early stage non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Gene replacement therapy for non-small cell lung cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Apoptosis and chemotherapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Identification of p53 genetic suppressor elements which confer resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Regulation of p53 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Dynamics of the p53-Mdm2 feedback loop in individual cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Apaf-1 is a transcriptional target for E2F and p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

The regulation of APAF1 expression during development and tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

7 January 2021

Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer. Thoracic Oncology Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

7 January 2021

Cisplatin: from DNA damage to cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

7 January 2021

Molecular Pathogenesis of Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

7 January 2021

Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

7 January 2021

Identification of genes that mediate sensitivity to cisplatin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

7 January 2021

Signaling to p53: breaking the MDM2-p53 circuit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

7 January 2021

A genetic approach to mapping the p53 binding site in the MDM2 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701094

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701094

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference